| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $4.7M+407.6% | $919K+375.3% | $193K | — | — | — |
| Cost of revenue | $1.9M+204.4% | $619K+465.8% | $109K | — | — | — |
| Research and development | $1.3M-48.3% | $2.5M-1.0% | $2.5M+138.0% | $1.1M+0.0% | $1.1M | — |
| General and administrative | $3.6M+54.0% | $2.4M-23.1% | $3.1M+60.6% | $1.9M+1073.0% | $163K+1292.7% | $12K |
| Total operating expenses | $6.8M+24.2% | $5.5M-3.9% | $5.7M+52.8% | $3.7M | — | — |
| Loss from operations | -$2.1M+53.1% | -$4.6M+17.2% | -$5.5M-47.6% | -$3.7M | — | — |
| Interest income | $113K+11200.0% | $1K-16.0% | $1K-43.2% | $2K | — | — |
| Amortization of discount on convertible notes | -$715K | — | — | — | — | — |
| Changes in fair value of derivative liabilities | -$278K | — | — | — | — | — |
| Total other income (expense), net | -$880K-88100.0% | $1K-99.2% | $130K-53.8% | $282K+614.4% | $39K+3845.0% | $1K |
| Loss before income tax expense | -$3.0M+33.8% | -$4.6M+15.2% | -$5.4M-55.9% | -$3.5M-1495.0% | -$216K-1608.0% | -$13K |
| Income tax expense | — | — | — | — | $800 | — |
| Net loss | -$3.0M+33.8% | -$4.6M+15.2% | -$5.4M-55.9% | -$3.5M-1489.2% | -$217K-1512.5% | -$13K |
| Net loss per share - basic (in Dollars per share) | -$0.23+37.8% | -$0.37+21.3% | -$0.47-46.9% | -$0.32-433.3% | -$0.06-200.0% | -$0.02 |
| Net loss per share - diluted (in Dollars per share) | -$0.23+37.8% | -$0.37 | — | — | — | — |
| Weighted average common shares outstanding - basic (in Shares) | 13.17B+7.1% | 12.30B+107974.8% | 11.4M+6.8% | 10.7M+192.3% | 3.6M+550.0% | 561K |
| Weighted average common shares outstanding - diluted (in Shares) | 13.17B+7.1% | 12.30B | — | — | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.